OLE Study With Filgotinib in JIA

Clinical trial NCT07553182 · RECRUITING

Trial details

NCT number: NCT07553182
Sponsor: Alfasigma S.p.A.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Juvenile Idiopathic Arthritis (JIA)

Start date: 2026-04-20
Primary completion: 2027-12-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.